If youre bullish on oil, then Continental Resources (CLR) is the stock for you. I believe the company will likely significantly grow its earnings in 2018 due to higher realized prices and around 20% production growth. Meanwhile the company, which burned cash flows in 2017, will likely report str
The U.S. stock market closed out another quiet week with small losses on Friday. The market opened the session lower and then climbed through mid-day. After an early afternoon selloff, the major averages closed near their best levels of the day.
Gainers included The GEO Group (NYSE: GEO), which jumped almost 22 percent a day after plunging nearly 40 percent on news that the U.S. government....More>>>
German property stocks have had a good year, which reflects two things: (1) strong dynamics in German property, primarily based on solid economic growth (ECB forecasts ~1.6% real GDO growth through 2018) and (2) negative ECB deposit rates, which lower financing costs for developers and landlord while also forcing institutional buyers (insurance companies, pension funds and asset managers) into real....More>>>
Many developing and new traders struggle with comprehending the difference between the trades that will work from the trades that will not work, so veteran trader Mike Bellafiore of SMB Capital suggests they spice up their smart trade ideas with these four extra ingredients.
Here’s what I see from my seat as the managing partner of a proprietary trading desk in NYC with underperforming....More>>>
The U.S. stock market suddenly woke up on Friday after nearly two months of sleepy sideways trading. The primary catalyst was the notion that the Fed might actually raise interest rates at their next policy meeting on September 20-21. If this is indeed the reason for the sell-off, it should not have come as a surprise to investors, as the Fed has been consistently stating since late July that a....More>>>
On August 30, the Food and Drug Administration (FDA) approved Novartis’ (NYSE:NVS) Erelzi, a biosimilar to Amgen’s (NASDAQ:AMGN) biggest seller, Enbrel. Erelzi is the second biosimilar available in the U.S. after Zarxio, also by Novartis, and again a biosimilar to another of Amgen’s top products, Neupogen. Amgen has been trying its best to offset these challenges by advancing new....More>>>
The Internal Revenue Service announced more tax relief today for victims of Hurricane Harvey, this time lifting hurdles to accessing retirement funds. Its usually hard to qualify for an in-service distribution from your workplace retirement plan, but the IRS is bending the rules for storm victims
High-income retirees socked with premium surcharges for Medicare Part B and Part D may have to pony up even more in 2018. The income thresholds for the highest surcharge tiers drop next year, hitting more beneficiaries with higher premiums.